Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Multi-institutional Trial of NOVO-TTF-100A, BCNU and Bevacizumab for GBM in First Relapse

NCT02348255 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT02348255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02348255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Multi-institutional Trial of NOVO-TTF-100A, BCNU and Bevacizumab for GBM in First Relapse
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 2016
Completion date
January 31, 2017
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adult brain glioblastoma, recurrent adult brain neoplasm